Invictus Private Wealth, LLC Harrow Health, Inc. Transaction History
Invictus Private Wealth, LLC
- $1.13 Trillion
- Q1 2024
A detailed history of Invictus Private Wealth, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Invictus Private Wealth, LLC holds 21,000 shares of HROW stock, worth $513,240. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,000
Previous 21,000
-0.0%
Holding current value
$513,240
Previous $235 Million
18.13%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
127Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$95.8 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$73.6 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$53.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$44.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$23.3 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $662M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...